Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Colorectal Cancer
• Esophagus Cancer
• Gastric Cancer
• Glioma
• Hepatoma
• Lung Cancer
• Lymphoma
• Melanoma
• Mesothelioma
• Multiple Myeloma
• Myeloid Leukemia
• Ovarian Cancer
• Pancreatic Cancer
• Renal Carcinoma
• Synovial Sarcoma

Snippet

Sponsor: Shenzhen BinDeBio Ltd. | Conditions: B-cell Acute Lymphoblastic Leukemia, Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN